Publication in
Presents to MST Access Australian Micro & Small Caps Conference
Cash balance at 30 June 2021 of A$28M
MELBOURNE, Australia, July 30, 2021 /PRNewswire/ Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ( Alterity or the Company ), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2021 (Q4 FY21).
The Company’s cash position at 30 June 2021 of $28M was bolstered by the receipt of $17M in net proceeds from the use of the company’s previously approved At the Market facility with shares issued in accordance with ASX Listing Rules 7.1 and 7.1A.
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Alterity Therapeutics : Appendix 4C - Q4 FY21 Quarterly Cash Flow Report
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.